MedTech Dive July 22, 2024
The device is designed to perform the most commonly ordered blood tests, avoiding the need to send the samples to central labs.
Dive Brief:
- Truvian Health has raised $74 million to support a filing for clearance of its benchtop blood test instrument, the company said Wednesday.
- The device is designed to perform routine blood tests, freeing clinics, doctor’s offices and pharmacies from the need to send samples to central labs.
- Truvian has shared research on its platform in a preprint study and in posters at medical conferences.
Dive Insight:
Truvian has identified reliance on central labs for processing blood samples as a barrier to the timely and cost-effective diagnosis and monitoring of health conditions. Healthcare providers can need...
Today's Sponsors
Today's Sponsor